Quotes 5-day view Delayed Nyse
11/18/2020
11/19/2020
11/20/2020
11/23/2020
11/24/2020
Date
163.5(c)
166.31(c)
166.2(c)
164.34(c)
161.06(c)
Last
1 457 816
1 329 244
1 217 711
1 493 220
2 425 927
Volume
-1.17% +1.72% -0.07% -1.12% -2.00% Change
Sales 2020
6 606 M - -
Net income 2020
1 659 M - -
Net Debt 2020
3 277 M - -
P/E ratio 2020
47,4x
Yield 2020
0,49%
Sales 2021
7 096 M - -
Net income 2021
1 882 M - -
Net Debt 2021
2 436 M - -
P/E ratio 2021
40,2x
Yield 2021
0,56%
Capitalization
76 547 M 76 547 M -
EV / Sales 2020
12,1x
EV / Sales 2021
11,1x
Nbr of Employees
10 600
Free-Float
94,6%
Zoetis specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows:
- pets (50.2%): cats and dogs (93.8% of net sales) and horses (6.2%);
- livestock (48.4%): cattle (54.6% of sales), swine (20.2%), poultry (18.4%), fish (4.4%) and other (2.4%);
- other (1.4%).
Net sales break down by family of products into vaccines (23.7%), antiinfectives (20%),...
Notations Surperformance© of Zoetis
Trading Rating : Investor Rating :
News in other languages on ZOETIS
Analyst Recommendations on ZOETIS
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends ZOETIS
Short Term Mid-Term Long Term Trends Neutral Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
21
Average target price
180,88 $
Last Close Price
161,06 $
Spread / Highest target
30,4%
Spread / Average Target
12,3%
Spread / Lowest Target
-22,4%
Please enable JavaScript in your browser's settings to use dynamic charts.
1st jan. Capitalization (M$)
ZOETIS 21.69% 76 547
Canada
Deutschland
France
Schweiz (DE)
United Kingdom
Report
